z-logo
open-access-imgOpen Access
Urogenital function following robotic and laparoscopic rectal cancer surgery: meta-analysis
Author(s) -
Christina Fleming,
Carolyn Cullinane,
Noel Lynch,
S D Killeen,
John Calvin Coffey,
C Peirce
Publication year - 2021
Publication title -
british journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.202
H-Index - 201
eISSN - 1365-2168
pISSN - 0007-1323
DOI - 10.1093/bjs/znaa067
Subject(s) - medicine , sexual function , prostate cancer , surgery , genitourinary system , meta analysis , cancer
Background Mixed results are reported on clinical and cancer outcomes in laparoscopic rectal cancer surgery (LRCS) compared with robotic rectal cancer surgery (RRCS). However, more favourable functional outcomes are reported following RRCS. This study compared urinary and sexual function following RRCS and LRCS in male and female patients. Methods A systematic review and meta-analysis of urinary and sexual function after RRCS and LRCS was performed following PRISMA and MOOSE guidelines, and registered prospectively with PROSPERO (ID:CRD42020164285). The functional outcome reporting tools most commonly included: the International Prostate Symptom Score (IPSS), International Index of Erectile Function (IIEF) and Female Sexual Function Index (FSFI). Mean scores and changes in mean scores from baseline were analysed using RevMan version 5.3. Results Ten studies were included reporting on 1286 patients. Some 672 patients underwent LRCS, of whom 380 (56.5 per cent) were men and 116 (17.3 per cent) were women (gender not specified in 176 patients, 26.2 per cent). A total of 614 patients underwent RRCS, of whom 356 (58.0 per cent) were men and 83 (13.5 per cent) were women (gender not specified in 175 patients, 28.5 per cent). Regarding urinary function in men at 6 months after surgery, IPSS scores were significantly better in the RRCS group than in the LRCS group (mean difference (MD) −1.36, 95 per cent c.i. −2.31 to −0.40; P = 0.005), a trend that persisted at 12 months (MD −1.08, −1.85 to −0.30; P = 0.007). ΔIIEF scores significantly favoured RRCS at 6 months [MD –3.11 (95%CI –5.77, –0.44) P <0.021] and 12 months [MD –2.76 (95%CI –3.63, –1.88) P <0.001] post-operatively. Mixed urinary and sexual function outcomes were reported for women. Conclusion This meta-analysis identified more favourable urinary and erectile function in men who undergo robotic compared with conventional laparoscopic surgery for rectal cancer. Outcomes in women did not identify a consistently more favourable outcome in either group. As robotic rectal cancer surgery may offer more favourable functional outcomes it should be considered and discussed with patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom